Division of Vascular Surgery and Endovascular Therapy, University of Florida College of Medicine, Gainesville, Fla.
Division of Cardiac, Thoracic, and Vascular Surgery, Department of Surgery, NewYork-Presbyterian/Columbia University Irving Medical Center, New York, NY.
J Vasc Surg. 2020 Aug;72(2):589-596.e3. doi: 10.1016/j.jvs.2019.10.072. Epub 2020 Feb 14.
The timing of operative revascularization for patients with concomitant carotid artery stenosis and coronary artery disease remains controversial. We examined the Society of Thoracic Surgeons (STS) Adult Cardiac Surgery Database to evaluate the association of combined carotid endarterectomy (CEA) and coronary artery bypass grafting (CABG) with postoperative outcomes.
All patients undergoing CABG with known carotid stenosis of >80% were identified from 2011 to 2016. Individuals were stratified by use of cardiopulmonary bypass and whether a concomitant CEA was performed at the time of CABG. Multivariate logistic regression was used to model the probability of combined CABG and CEA. The resulting propensity scores were used to match individuals on the basis of clinical and operative characteristics to evaluate primary (30-day mortality and in-hospital transient ischemic attack and stroke) and secondary (STS morbidity composite events and length of stay) end points, with P < .05 required to declare statistical significance.
After propensity score matching, 994 off-pump CABG patients (497 CABG only and 497 CABG-CEA) and 5952 on-pump CABG patients (2976 CABG only and 2976 CABG-CEA) were identified. For patients who received on-pump operations, those undergoing CABG-CEA had no observed difference in rate of in-hospital stroke (odds ratio [OR], 0.93; 95% confidence interval [CI], 0.72-1.21; P = .6), higher incidence of STS morbidity composite events (OR, 1.15, 95% CI, 1.01-1.31; P = .03), longer length of stay (7.0 [interquartile range, 5.0-9.0] days vs 6.0 [interquartile range, 5.0-9.0] days; P < .005), and no observed difference in 30-day mortality (OR, 1.28; 95% CI, 0.97-1.69; P = .08) compared with those undergoing CABG only. For off-pump procedures, CABG-CEA patients had no observed difference in rate of in-hospital stroke (OR, 0.80; 95% CI, 0.37-1.69; P = .56) compared with those undergoing CABG only.
Whereas the differences are relatively small, these data suggest that a combined CABG-CEA approach is unlikely to provide significant stroke reduction benefit compared with CABG only. However, comparison with staged approaches merits further investigation.
同时患有颈动脉狭窄和冠状动脉疾病的患者行血管重建术的时机仍存在争议。我们利用胸外科医师学会(STS)成人心脏手术数据库评估同期颈动脉内膜切除术(CEA)和冠状动脉旁路移植术(CABG)联合应用的术后结局。
从 2011 年至 2016 年,我们确定了所有接受 CABG 且已知颈动脉狭窄>80%的患者。根据体外循环的使用情况以及 CABG 时是否同时进行 CEA 将患者分层。多变量逻辑回归用于建立同时行 CABG 和 CEA 的概率模型。根据临床和手术特点,利用由此产生的倾向评分对患者进行匹配,以评估主要终点(30 天死亡率、院内短暂性脑缺血发作和卒中)和次要终点(STS 发病率综合事件和住院时间),需要 P<0.05 才能宣布具有统计学意义。
经倾向评分匹配后,共纳入 994 例非体外循环 CABG 患者(497 例仅行 CABG 和 497 例 CABG-CEA)和 5952 例体外循环 CABG 患者(2976 例仅行 CABG 和 2976 例 CABG-CEA)。对于接受体外循环手术的患者,与仅行 CABG 患者相比,行 CABG-CEA 者院内卒中发生率无显著差异(比值比[OR],0.93;95%置信区间[CI],0.72-1.21;P=0.6),STS 发病率综合事件发生率较高(OR,1.15,95%CI,1.01-1.31;P=0.03),住院时间较长(7.0[四分位间距,5.0-9.0]d 比 6.0[四分位间距,5.0-9.0]d;P<0.005),30 天死亡率无显著差异(OR,1.28;95%CI,0.97-1.69;P=0.08)。对于非体外循环手术,与仅行 CABG 患者相比,行 CABG-CEA 者院内卒中发生率无显著差异(OR,0.80;95%CI,0.37-1.69;P=0.56)。
虽然差异相对较小,但这些数据表明,与仅行 CABG 相比,同期行 CABG-CEA 不太可能显著降低卒中发生率。然而,与分期治疗方法相比,这种方法值得进一步研究。